Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens
Open Access
- 6 June 2018
- journal article
- research article
- Published by S. Karger AG in Acta Cytologica
- Vol. 62 (4) , 302-310
Abstract
Objectives: Telomerase activity can be detected in up to 90% of urothelial carcinomas (UC). Telomerase activity can also be detected in urinary tract cytology (UTC) specimens and indicate an increased risk of UC. We evaluated the performance of a commercially available antibody that putatively binds the telomerase reverse transcriptase (hTERT) subunit on 500 UTC specimens. Study Design: Unstained CytospinTM preparations were created from residual urine specimens and were stained using the anti-hTERT antibody (SCD-A7). Two algorithms were developed for concatenating the hTERT result and cytologic diagnosis: a “no indeterminates algorithm,” in which a negative cytology and positive hTERT result are considered positive, and a “high-specificity algorithm,” in which a negative cytology and positive hTERT result are considered indeterminate (and thus negative for comparison to the gold standard). Results: The “no indeterminates algorithm” and “high-specificity algorithm” yielded a sensitivity of 60.6 and 52.1%, a specificity of 70.4 and 90.7%, a positive predictive value of 39.1 and 63.8%, and a negative predictive value of 85.0 and 85.8%, respectively. Conclusions: A positive hTERT result may identify a subset of patients with an increased risk of high-grade UC (HGUC) who may otherwise not be closely followed, while a negative hTERT immunocytochemistry result is associated with a reduction in risk for HGUC.Keywords
This publication has 21 references indexed in Scilit:
- The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized TerminologyActa Cytologica, 2016
- A review of the Paris system for reporting urinary cytologyCytopathology, 2016
- The cytomorphological features of low‐grade urothelial neoplasms vary by specimen typeCancer Cytopathology, 2016
- Accuracy and Interobserver Variability of the Cytologic Diagnosis of Low-Grade Urothelial Carcinoma in Instrumented Urinary Tract Cytology SpecimensAmerican Journal of Clinical Pathology, 2015
- Prevalence of Telomerase Activity in Human CancerJournal of the Formosan Medical Association, 2011
- Clinical model of lifetime cost of treating bladder cancer and associated complicationsUrology, 2006
- Multiprobe FISH for Enhanced Detection of Bladder Cancer in Voided Urine Specimens and Bladder WashingsAmerican Journal of Clinical Pathology, 2001
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997
- Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urineCancer, 1997
- Superficial Bladder Cancer: Progression and RecurrenceJournal of Urology, 1983